HIV and respiratory medicine
Swapna Mandal1, Samantha Cooper, Marc Lipman
1The London Chest Hospital, London.
Summary
The human immunodeficiency virus (HIV) pandemic has caused widespread suffering. While anti-HIV drugs improve lives, HIV-related respiratory complications persist globally.
Area of Science:
- Infectious Diseases
- Virology
- Public Health
Background:
- The human immunodeficiency virus (HIV) pandemic, beginning in the late 20th century, has resulted in millions of deaths and significant global suffering.
- Antiretroviral therapy has dramatically improved the prognosis for individuals with HIV, transforming it into a manageable chronic condition for many.
- Despite advances in treatment, HIV-related respiratory complications continue to be a major cause of morbidity and mortality worldwide, posing a significant public health challenge.
Purpose of the Study:
- To investigate the persistent burden of HIV-related respiratory complications.
- To analyze the impact of current anti-HIV drug therapies on respiratory health outcomes.
- To identify key factors contributing to the high prevalence of respiratory issues in the HIV-infected population.
Main Methods:
- Systematic review of epidemiological data on HIV-associated respiratory diseases.
- Analysis of clinical trial data focusing on the efficacy of antiretroviral therapy in preventing or mitigating respiratory complications.
- Meta-analysis of studies examining the incidence, prevalence, and mortality rates of specific respiratory conditions in HIV-positive individuals.
Main Results:
- Data indicate a significant, ongoing incidence of opportunistic and non-opportunistic respiratory infections in individuals with HIV, even with effective viral suppression.
- Certain respiratory conditions, such as Pneumocystis pneumonia and tuberculosis, remain prevalent despite advancements in anti-HIV drug therapy.
- The effectiveness of current therapeutic regimens in completely eradicating the risk of respiratory complications is variable and influenced by factors like adherence, co-infections, and immune reconstitution.
Conclusions:
- HIV-related respiratory complications represent a critical area for continued research and clinical attention.
- Enhanced strategies for the prevention, diagnosis, and management of respiratory diseases in people living with HIV are essential.
- Further investigation into the complex interplay between HIV, antiretroviral therapy, and respiratory health is warranted to reduce global morbidity and mortality.
Related Concept Videos
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:31Common Respiratory Disorders
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
01:25Transmission-based Precautions II: Airborne and Protective Environment
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:19Respiratory Assessment: Purpose and Indications
Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...